Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10918963 | Radiotherapy and Oncology | 2012 | 5 Pages |
Abstract
This study demonstrates that the majority of late GI and GU side effects after primary external beam radiotherapy for prostate cancer are transient. Using only actuarial incidence rates for reporting side effects may lead to misinterpretation or overestimation. The combination of incidence and prevalence rates provides a more comprehensive view on the complex issue of late side effects.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Maximilian P. Schmid, Richard Pötter, Valentin Bombosch, Samir Sljivic, Christian Kirisits, Wolfgang Dörr, Gregor Goldner,